Serum decoy receptor 3 is a biomarker for disease severity in nonatopic asthma patients

High serum DcR3 levels are associated with disease severity in nonatopic asthma patients, which suggests that DcR3 is a potential biomarker that can be used to predict the severity of nonatopic asthma.